NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Attenuates TrxR by alkylation of C-terminal redox-active site Ser498; inhibits Trx/TrxR expression facilitating ROS accumulation in human cervical cancer cells [179]Suppresses TNF-α-mediated activation of NFκB in CML cells and AML leukemia cells[180]